Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
20.10+0.07 (+0.35%)
At close: 04:00PM EDT
19.75 -0.35 (-1.74%)
After hours: 04:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 601.00M
Enterprise value 192.10M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.07
Price/book (mrq)0.53
Enterprise value/revenue 0.66
Enterprise value/EBITDA -3.91

Trading information

Stock price history

Beta (5Y monthly) 1.42
52-week change 3-32.78%
S&P500 52-week change 322.36%
52-week high 344.09
52-week low 319.88
50-day moving average 322.22
200-day moving average 327.54

Share statistics

Avg vol (3-month) 3214.42k
Avg vol (10-day) 3166.31k
Shares outstanding 529.9M
Implied shares outstanding 629.9M
Float 819.89M
% held by insiders 132.58%
% held by institutions 149.08%
Shares short (15 Apr 2024) 4625.35k
Short ratio (15 Apr 2024) 43.72
Short % of float (15 Apr 2024) 43.80%
Short % of shares outstanding (15 Apr 2024) 42.09%
Shares short (prior month 15 Mar 2024) 4611.22k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -58.03%
Operating margin (ttm)-47.50%

Management effectiveness

Return on assets (ttm)-3.47%
Return on equity (ttm)-14.58%

Income statement

Revenue (ttm)289.21M
Revenue per share (ttm)9.71
Quarterly revenue growth (yoy)4.10%
Gross profit (ttm)N/A
EBITDA -46.55M
Net income avi to common (ttm)-167.82M
Diluted EPS (ttm)-5.63
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)424.15M
Total cash per share (mrq)14.24
Total debt (mrq)13.59M
Total debt/equity (mrq)1.20%
Current ratio (mrq)6.95
Book value per share (mrq)38.31

Cash flow statement

Operating cash flow (ttm)27M
Levered free cash flow (ttm)26.29M